4DMedical Limited (ASX:4DX)
Australia flag Australia · Delayed Price · Currency is AUD
3.710
+0.020 (0.54%)
Feb 26, 2026, 3:49 PM AEST

4DMedical Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
2,111112213231174361
Market Cap Growth
929.96%-47.65%-7.71%33.09%-51.84%-
Enterprise Value
2,109101170191115318
Last Close Price
3.690.240.520.670.591.23
PS Ratio
360.7119.0956.84321.80164.801662.62
PB Ratio
32.871.743.013.242.924.33
P/TBV Ratio
--81.563.282.974.36
EV/Sales Ratio
-17.1945.30266.08108.941467.87
Debt / Equity Ratio
0.070.070.070.070.110.02
Net Debt / Equity Ratio
-0.04-0.04-0.36-0.90-0.75-0.95
Net Debt / EBITDA Ratio
0.060.060.581.471.243.28
Net Debt / FCF Ratio
0.070.070.822.791.615.25
Asset Turnover
0.050.050.040.010.010.00
Inventory Turnover
0.490.490.290.109.991.08
Quick Ratio
0.740.741.674.746.0110.39
Current Ratio
0.890.891.784.866.1610.51
Return on Equity (ROE)
-44.49%-44.49%-50.54%-48.04%-34.43%-59.88%
Return on Assets (ROA)
-27.64%-27.64%-26.43%-33.31%-27.52%-28.05%
Return on Capital Employed (ROCE)
-62.90%-62.90%-45.90%-58.10%-56.80%-28.80%
Earnings Yield
-1.42%-26.91%-16.86%-13.61%-14.15%-5.94%
FCF Yield
-1.64%-30.93%-14.54%-9.98%-16.07%-4.18%
Buyback Yield / Dilution
-14.52%-14.52%-23.49%5.59%-12.14%-92.94%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.